Audited Supplier
In This Store
Guangdong Jiabo Pharmaceutical Co., Ltd. (hereinafter abbreviated as Jiabo Pharm) has a R & D team composed of professional researchers, doctors and masters now. Over recent years, the R&D center has actively carried out proprietary R&D projects, participated in and undertaken a number of national, provincial and municipal science & technology projects, owned a number of authorized invention patents and utility model patents, and won the honorary title of China Patent Award. Relying on the R&D center, the company actively carries out cooperation with foreign parties, and has successively established technology platforms such as the Production, Study & Research Base of Sun Yat Sen University, Guangdong Intravenous Fat Emulsion Engineering Technology Research Center and Guangdong Postdoctoral Innovation Practice Base, so as to improve the R&D and innovation ability of the company and push the high-quality development of the company.
The company, with perfect product layout, has many GMP production lines such as small volume parenterals, large volume parenterals, sterilized small volume parenteral, soft bag line and API, as well as a production line in line with EU standard (to be certified), which can meet the industrialized production of various complex injections. At present, the R&D pipeline reserve is sufficient, many products with market potentiality are to be launched, and the production technology and related quality control technology of complex injections such as liposome and fat emulsion are advanced over other domestic manufacturers.
Year of Establishment: 2003
Total Assets(USD):
Total Number of Staff: 500-1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Reputation,Quality Service
Other Competitive Advantages: Jiabo technology platform is committed to the research in the field of perioperative anesthesia and drug delivery system for injection. Various of R&D platforms, including Qingyuan Engineering Technology R&D Center for Microemulsion Delivery System, Guangdong Engineering and Technology Research Center for Intravenous Fat Emulsion, Guangdong Postdoctoral Innovation Practice Base, Guangdong Enterprise Technology Center, Guangdong Doctoral Workstation and National Postdoctoral Workstation (substation) , have been successively established. With a R&D team of up to 90 personnel, Jiabo lays a good foundation for scientific research and innovation by introducing Qingyuan research and innovation team for intravenous fat emulsion, Yangfan plan for core technology of lipid-based drug delivery system and industrialization team, as well as Dr. Cai Tingwei who returned from overseas and graduated from Ohio State University with his major in pharmaceutical chemistry.
Patents and Copyrights: In recent years, Jiabo technology platform has made great achievements in research and development projects, approved manufacturing licenses and patents. In 2012, Jiabo was entrusted by regulatory authority to draft the national quality standard of Propofol injection. The major products, such as Propofol Injectable Emulsion, Propofol Medium and Long Chain Fat Emulsion Injection, Ropivacaine Hydrochloride Injection and Methoxamine Hydrochloride Injection, have been accredited as high&new technology product. Jiabo has won the 16th China Patent Excellence Award, the first prize of Qingyuan Science&Technology Progress Award, the third prize of Guangdong Science&Technology Award, the first prize of “Innovative Qingyuan” science and technology award in 2021 and Guangdong "May Day Labor Award" in 2021.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight January 2025
